Dr Nathan Kerr was featured by Bloomberg for research of the PolyActiva implant.
The PolyActiva implant, undergoing clinical trials, slowly releases glaucoma medication and may reduce or eliminate the need for daily eye drops.
Dr Nathan Kerr with the world’s first PolyActiva implant recipient.
A needle in the eye may soon improve care for blinding glaucoma pic.twitter.com/bsLeJT0AY3
— TicToc by Bloomberg (@tictoc) August 31, 2018
About The Author: Dr Nathan Kerr
Dr Nathan Kerr is an internationally-recognised expert in minimally invasive glaucoma surgery
More posts by Dr Nathan Kerr